Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kimberlee C. Drapkin currently holds 12,500 shares of Jounce Therapeutics, Inc. (JNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kimberlee C. Drapkin has been a net seller of JNCE stock. They have purchased $0 and sold $827.4K worth of shares.
Kimberlee C. Drapkin's most recent insider trade was on Jun 30, 2025, when they sold 13,794 shares at $0.00 per share.
Kimberlee C. Drapkin serves as Executive at Jounce Therapeutics, Inc. (JNCE). They have executed 45 insider transactions totaling $827.4K over their tenure at the company.
Kimberlee C. Drapkin holds the position of Executive at Jounce Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kimberlee C. Drapkin has shown a selling trading pattern, with $0 in total purchases and $827.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kimberlee C. Drapkin was on Jan 20, 2021, when they sold $194.9K worth of JNCE shares. This transaction involved 16,201 shares at $12.03 per share.
Kimberlee C. Drapkin currently owns 12,500 shares of Jounce Therapeutics, Inc. (JNCE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kimberlee C. Drapkin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kimberlee C. Drapkin has 45 Form 4 filings on record as an insider at Jounce Therapeutics, Inc..
Set alerts for Kimberlee C. Drapkin and 40,000+ other insiders.